Datar Cancer Genetics to Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer Patients

DCG's advanced platform uses human-supervised AI to analyze high-resolution, real-time videos of tumor cells exposed to chemotherapy drugs. These time-lapse videos provide clear, verifiable evidence to support treatment decisions. "For the first time, we can see how a patient's cancer cells respond to various chemotherapy treatments before administration," said Dr. Darshana Patil, Senior Director-Global Strategy and Medical Affairs. DCG's advanced platform uses human-supervised AI to analyze...

DCG's advanced platform uses human-supervised AI to analyze high-resolution, real-time videos of tumor cells exposed to chemotherapy drugs. These time-lapse videos provide clear, verifiable evidence to support treatment decisions. "For the first time, we can see how a patient's cancer cells respond to various chemotherapy treatments before administration," said Dr. Darshana Patil, Senior Director-Global Strategy and Medical Affairs.

Chemotherapy remains a cornerstone of cancer treatment, but treatment failure due to empirical drug selection is common. The absence of molecular biomarkers for many drugs increases risks of inefficacy and adverse effects. DCG's platform bridges this gap, improving decision-making and enhancing outcomes by reducing risks associated with ineffective therapies.

Key Features:

Validated through rigorous trials, the platform has been adopted by major oncology centers, demonstrating improved treatment success and patient satisfaction. "This evidence-based approach revolutionizes cancer care by enhancing transparency and optimizing treatment selection," said Dr. Vineet Datta, Senior Director-Global Strategy and Business Development.

www.datarpgx.com
www.chemoscale360.com

About Datar Cancer Genetics
DCG is a global oncology leader developing non-invasive technologies for cancer detection and treatment. With CAP and CLIA accredited facilities in the UK and India, DCG serves patients worldwide, advancing precision cancer care.

 

Photo: https://mma.prnewswire.com/media/2607599/DATAR_Chemotherapy.jpg
Logo: https://mma.prnewswire.com/media/2602388/5138139/Datar_Cancer_Genetics_Logo.jpg

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/datar-cancer-genetics-to-provide-groundbreaking-video-enhanced-results-of-in-vitro-chemotherapy-effectiveness-tests-for-cancer-patients-302361686.html